New clinical cleanroom manufacturing and training facility launches in Brisbane

The Hon Karen Andrews, Minister for Industry, Science and Technology is opening the Translational Research Institute’s (TRI) new state-of-the-art clinical cleanroom manufacturing and training facility, T3 Cleanrooms, and the inaugural MTPCareers Symposium on Wednesday 14 October 2020.

The new cleanroom facility will help significantly speed-up the translation of Australian medical innovations into clinical practice, and will be available to researchers, start-ups and companies to manufacture sterile products on a small scale.

Professor Scott Bell, CEO of the TRI says the T3 Cleanroom facility is the outcome of a successful partnership with Australian biotech, Vaxxas Pty Ltd, to secure funding from MTPConnect to build clinical manufacturing and training capacity.

Based in dedicated commercial space at TRI, Vaxxas worked with us to identify a critical gap in medtech manufacturing and skills for companies needing to scale-up production for clinical trials, which led TRI

Read More

Alec Baldwin Backs New Invisismart Mask, Cutting Edge Technology, Endorsed By Clinical Test And Scientist That Kills 99.99% Of SARS CoV-2 Germs

NEW YORK, Oct. 10, 2020 /PRNewswire/ — Alec Baldwin may be the funniest character on popular SNL, but when it comes to his 5 kids, his brothers and his family, he is very serious. Alec and his brother Daniel Baldwin, have done their homework and they have jointly decided to share the lifesaving INVISISMART Mask & Shield with the world.

During a Pandemic it is important to STAY SAFE and be able to LIVE LIFE. InvisiSmart is an engineered next-generation solution that kills 99.99% of SARS CoV-2 germs. It provides your loved ones, people, healthcare professionals, athletes and businesses with long-lasting invisible protection.

InvisiSmart technology is verified by robust laboratory and clinical evidence, and comes as a Mask, Shield Spray, Seat Covers, and Sanitizer. It is important to note that InvisiSmart is a long lasting product that doesn’t use carcinogens.

INVISISMART Technologies has been proven to destroy the COVID-19 spike

Read More

Abby Abraham Joins George Clinical to lead Global Data Science and head India Business

Abby Abraham Joins George Clinical to lead Global Data Science and head India Business

PR Newswire

OVERLAND PARK, Kan., Oct. 8, 2020

OVERLAND PARK, Kan., Oct. 8, 2020 /PRNewswire/ — Abby Abraham, a veteran clinical researcher and data science lead, has joined George Clinical, a global scientifically-backed clinical research organization, to head up the organization’s Global Data Science team and operations in India.

George Clinical Science. Service. Solutions. (PRNewsfoto/George Clinical)
George Clinical Science. Service. Solutions. (PRNewsfoto/George Clinical)

Abraham, a progressive clinical research professional passionate about altering the existing clinical research execution paradigm by bringing together competent and engaged people, brings George Clinical a deep knowledge of novel technologies and smart data processes.  He has more than 20 years of experience in the clinical technology industry working with global CROs including progression through multiple roles within clinical operations and general management.

“I am very pleased and delighted to welcome Abby to George Clinical to head up

Read More

Yardi Releases Kno2 Integration for Clinical Information Exchange | News

SANTA BARBARA, Calif., Oct. 5, 2020 /PRNewswire/ — Yardi® has significantly expanded interoperability in Yardi® EHR through a new integration with Kno2®. Kno2’s Interoperability as a Service™ (IaaS) enables Yardi EHR clients to securely share clinical records with more than 2.4 million health care providers nationwide.

 

 

Although electronic health records are standard in hospitals and senior living communities, transferring patient data between systems remains challenging. Providers still regularly share clinical information via fax, phone or printouts. These manual methods can lead to mistakes and omissions, which impacts care continuity during critical transitions.

The Kno2 integration, available as an add-on for all Yardi EHR clients, allows senior living staff to streamline and receive clinical information, such as referrals coming from various sources, as well as participate in value-based care coordination. For incoming residents, health data automatically flows into Yardi EHR. If clinical information needs to be shared with an external

Read More

PolyU launches the first dedicated interdisciplinary master programme in medical physics to nurture future clinical and academic talents in the field

Demand for Medical Physicists continues to grow as cancer treatment evolves

HONG KONG, Sept. 23, 2020 /PRNewswire/ — As medical technology advances, breakthroughs in diagnosing and treating various critical illnesses are achieved, and as the design of patient treatment plans becomes more precise and personalised, healthcare practitioners are expected to keep abreast of the latest developments so as to master the most sophisticated technologies. In a cancer treatment team, members are specialised in their respective fields, yet they work together seamlessly to devise the most effective treatment for patients. One of the lesser-known of the specialists in such a team, the Medical Physicist, is responsible for formulating treatment plans, as well as monitoring and maintaining radiation equipment used to ensure precise, effective and safe delivery of treatment.

Medical Physicists specialise in radiation treatment technology, with their expertise spanning from diagnostic imaging to radiotherapy, and they are “strong backers” of

Read More

Clinical Evaluation of Individualized and Navigated Microsecond Pulsing Laser for Acute Central Serous Chorioretinopathy

Introduction

Central serous chorioretinopathy (CSC) is a pathology of the central zone of the retina occurring predominantly in young/middle-aged males. It is characterized by an idiopathic serous detachment of the neurosensory retina with leakage of fluid through the retinal pigment epithelium (RPE) into the subretinal space, which may be accompanied by detachment of the RPE.1 Local defects in RPE cells with violation of the blood-retinal barrier and pumping functions play an important role in the development of CSC. Treatment should aim to restore the external blood-retinal barrier without causing excessive damage to adjacent tissues.2–4 A common approach to treating CSC is focal laser photocoagulation of the retina at the leaking point based on fluorescein angiography (FA) images.2–10 With the active evolution of laser surgery and the development of the navigated laser system Navilas (OD-OS GmbH, Teltow, Germany), it is possible to control laser focus accurately. Treatment accuracy

Read More

Fred Hutch-led clinical trial shows new smartphone app helps smokers quit

IMAGE

IMAGE: The home screen of the iCanQuit app is seen here. The app is available for Android and iOS smartphone users.
view more 

Credit: Fred Hutch

SEATTLE — Sept. 21, 2020 — Scientists at Fred Hutchinson Cancer Research Center believe they’ve found a better of use of mobile technology to help adult cigarette smokers quit.

In a large clinical trial published in JAMA Internal Medicine, a team led by Dr. Jonathan Bricker, a professor in Fred Hutch’s Public Health Sciences Division, tested the efficacy of the new smartphone app iCanQuit against the National Cancer Institute’s QuitGuide. iCanQuit is based on acceptance and commitment therapy, or ACT, and QuitGuide is based on U.S. clinical practice guidelines.

While apps to quit smoking have been downloaded over 33 million times, there has been little proof they actually work. Using a rigorous double-blind, randomized clinical trial involving over 2,400 adult smokers throughout the

Read More

Signant Health Launches New eCOA Master Class Web Series Taught by Clinical Research Science and Technology Experts

PHILADELPHIA, Sept. 21, 2020 /PRNewswire/ — Signant Health today introduced “eCOA Explained,” a new Master Class web series designed to elevate the understanding and skills of clinical operations professionals interested in electronic clinical outcome assessments (eCOA).

The educational and complimentary class launches with three courses and 16 on-demand lessons designed for all levels of eCOA experience, as taught by 13 clinical research science and technology experts. To enroll and start learning, visit www.ecoaexplained.com. 

Lessons available now include:

Build Your eCOA Solution

  • eCOA 101: The Basics (Jill Platko, PhD)
  • How to Build an eDiary: What’s Involved (Brandy Morneau)
  • From Paper to ePRO Measures: Licensing, Migration and Translation (Alex Kalpadakis-Smith, PhD)
  • How to Make Translations Work for Everyone (Adina Tapalaga)
  • To BYOD or Not to BYOD? (Bill Byrom, PhD)
  • Complex Diaries: Best Practices and Considerations (Jill Platko, PhD)

Ensure Successful Operations

Read More

Fluidics for Preclinical, Life Science Research, and Clinical Applications Market: COVID-19 Business Continuity Plan | Evolving Opportunities With AMETEK Inc. and Blacktrace Holdings Ltd. | Technavio

LONDON–(BUSINESS WIRE)–The global fluidics for preclinical, life science research, and clinical applications market is expected to grow by USD 1.38 billion as per Technavio. This marks a significant market slow down compared to the 2019 growth estimates due to the impact of the COVID-19 pandemic in the first half of 2020. However, steady growth is expected to continue throughout the forecast period, and the market is expected to grow at a CAGR of almost 7%.

Request challenges and opportunities that influence COVID-19 pandemic – Request Free Sample Report on COVID-19 Impacts

Read the 120-page report with TOC on “Fluidics for Preclinical, Life Science Research, and Clinical Applications Market Analysis Report by Product (Software and accessories and Precision syringe pumps), Application (Clinical and Research), (North America, Europe, Asia, and ROW), and the Segment Forecasts, 2020-2024”.

https://www.technavio.com/report/fluidics-for-preclinical-life-science-research-and-clinical-applications-market-industry-analysis

The market is driven by increasing cellular research on chronic diseases. In addition,

Read More